Connect Education Workshop Details
Help
Advances in the Treatment of Multiple Myeloma
- Overview of Multiple Myeloma
- Current Standard of Care
- New Treatment Options
- How Clinical Trials Contribute to Treatment Options
- Symptom and Pain Management
- Dental Care Before, During and After Treatment
- Communicating with Your Health Care Team
- Questions for Our Panel of Experts
Kenneth C. Anderson, MD Kraft Family Professor of Medicine, Harvard Medical School, Chief, Division of Hematologic Neoplasia, Director, LeBow Institute for Myeloma Therapeutics, Director, Jerome Lipper Multiple Myeloma Center, Vice Chair, Program in Transfusion Medicine, Department of Medical Oncology, Dana-Farber Cancer Institute |
|
Noopur Raje, MD Associate Professor of Medicine, Department of Medicine, Harvard Medical School, Director, Multiple Myeloma Program, Medical Oncology, Massachusetts General Hospital |
|
Douglas E. Peterson, DMD, PhD Chair, Program in Head & Neck Cancer and Oral Oncology, Neag Comprehensive Cancer Center, University of Connecticut Health Center |
|
Richard Dickens, MSW Blood Cancers Program Coordinator, Project Coordinator, Mind/Body Program, CancerCare |
|
American Cancer Society, American Pain Foundation, American Society of Clinical Oncology, Association of Clinicians for the Underserved, Association of Oncology Social Work, Black Women's Health Imperative, Blood & Marrow Transplant Information Network, The Bone and Cancer Foundation, Cancer Patient Education Network, Cancer Support Community, Education Network to Advance Cancer Clinical Trials, Intercultural Cancer Council, International Myeloma Foundation , Joe's House, Multinational Association of Supportive Care in Cancer, National Black Leadership Initiative on Cancer, National Bone Marrow Transplant Link, National Center for Frontier Communities, National Coalition for Cancer Survivorship, National Family Caregivers Association, National Marrow Donor Program, Research Advocacy Network, Vital Options International & The Group Room
an educational grant from Millennium: The Takeda Oncology Company.
August 11, 2010
